| First Author | Werner H | Year | 1998 |
| Journal | Brain Pathol | Volume | 8 |
| Issue | 4 | Pages | 771-93 |
| PubMed ID | 9804383 | Mgi Jnum | J:50554 |
| Mgi Id | MGI:1306938 | Doi | 10.1111/j.1750-3639.1998.tb00200.x |
| Citation | Werner H, et al. (1998) Mouse models of myelin diseases. Brain Pathol 8(4):771-93 |
| abstractText | Dys- and demyelination are the common endpoints of several inherited diseases of glial cells, which elaborate myelin and which maintain the myelin sheath very much like an external cellular organelle. Whereas some of the genes that are affected by mutations appear to be glial-specific, other genes are expressed in many cell types but their defect is restricted to oligodendrocytes or Schwann cells. Many of the disease genes and their encoded proteins have been studied with the help of mouse models, and a number of different molecular pathomechanisms have emerged which have been summarized in Figure 8. Some of the new concepts in the field, which have been addressed in this review, have only emerged because similar pathomechanisms were discovered for different myelin proteins. Mouse models have clearly helped to address both, the molecular pathology of myelin diseases and the normal function of myelin genes, but as discussed in this review, these questions turned out to be very different. Despite the progress in understanding the role of the abundant myelin proteins, there also remain a number of open questions that concern, among other things, the initial axon-glia recognition, the assembly process of the myelin sheath, and the long-term interaction of axons with their myelinating glia. Finally, animal models of human neurological diseases should not be restricted to the study of pathology, but they should also contribute to the development of experimental treatments. It is encouraging that a few attempts have been made. |
